<ѻýҕl>Cardiologist’s Date Rape Verdict; Feds Come Down on DOAC Price; POC Test for HF?ѻýҕl> Recent developments of interest in cardiovascular medicine Aug 20, 2024
<ѻýҕl>Here's How Compounders Make Popular Weight-Loss Drugsѻýҕl> From sourcing API to getting the final formulation just right Aug 19, 2024
<ѻýҕl>Is Medicare's Negotiated Drug Price List Worth Celebrating? Depends on Whom You Ask.ѻýҕl> Reactions from physician and consumer groups were positive, but drugmakers begged to differ Aug 16, 2024
<ѻýҕl>Medicare Unveils First 10 Negotiated Drug Pricesѻýҕl> Prices slashed by as much as 79% Aug 15, 2024
<ѻýҕl>SGLT2 Hesitance; Furosemide's Indication Grows; Legal Fight Over Entresto Genericѻýҕl> Recent developments of interest in cardiovascular medicine Aug 13, 2024
<ѻýҕl>GLP-1 Agonists for Diabetes Tied to Lower Hyperkalemia Ratesѻýҕl> Class was compared with DPP4-inhibitors Aug 12, 2024
<ѻýҕl>Dementia Risk Dropped With Anti-Inflammatory Diet for Certain Patientsѻýҕl> Brain markers of degeneration, injury were better, too Aug 12, 2024
<ѻýҕl>What's the Best Way to Help Specialists Succeed? Beef Up Primary Careѻýҕl> Let us handle the garden-variety hypertension and diabetes, and give them the complex cases Aug 12, 2024
<ѻýҕl>Poor Physical Function Likely the Main Reason for Higher Fracture Risk in T2Dѻýҕl> Skeletal characteristics may not be to blame among older women Aug 06, 2024
<ѻýҕl>Prescription-Free Online Semaglutide Is Risky Businessѻýҕl> Over 40% of pharmacy sites offering GLP-1 drug without a script are known to operate illegally Aug 05, 2024
<ѻýҕl>Aerosmith Retires After Injury; All Zepbound Doses Now Available; Guacamole Recalledѻýҕl> Health news and commentary gathered by ѻýҕl staff Aug 05, 2024
<ѻýҕl>NIH Loses in Court; NSYNC Member's New Diagnosis; Chief Resident Dies at 32ѻýҕl> Health news and commentary gathered by ѻýҕl staff Aug 02, 2024
<ѻýҕl>Semaglutide May Help Smokers Quit, Study Suggestsѻýҕl> Use for diabetes tied to fewer medical visits for tobacco use disorder versus other antidiabetics Jul 30, 2024
<ѻýҕl>Hint of Alzheimer's Benefit Seen With GLP-1 Drugѻýҕl> Slower cognitive decline, less brain volume loss in early liraglutide study Jul 30, 2024
<ѻýҕl>FDA Warns of Overdoses With Compounded Semaglutideѻýҕl> Multi-dose vials pose complications for self-administration Jul 29, 2024
<ѻýҕl>Kim Jong Un's Health Problems; Seine Olympic Event Nixed Again; Vegan Diet and Agingѻýҕl> Health news and commentary gathered by ѻýҕl staff Jul 29, 2024
<ѻýҕl>Can App Data Link Sleep and Chronic Disease?; AI Model to Manage Diabetesѻýҕl> Also in TTHealthWatch: a monoclonal antibody for ulcerative colitis Jul 27, 2024 podcast
<ѻýҕl>FBI Probes Trump's Injury; RFK Jr. Pushes Farm Therapy; Glucose Monitor Warningѻýҕl> Health news and commentary gathered by ѻýҕl staff Jul 26, 2024
<ѻýҕl>People Without Diabetes Make Up Growing Share of GLP-1 Usersѻýҕl> Approximately one-fourth of new users in 2023 did not have type 2 diabetes Jul 22, 2024
<ѻýҕl>Nasal Sprays for Respiratory Infections; Paxlovid in COVID Preventionѻýҕl> Also in TTHealthWatch: diabetes in kids after COVID Jul 20, 2024 podcast
<ѻýҕl>Industry $$ for New Cardiologists; Strokes After Falls; Self-Cleaning TAVR Valve?ѻýҕl> Recent developments of interest in cardiovascular medicine Jul 16, 2024
<ѻýҕl>We've Been Here Before: The Politicization of Drug Pricingѻýҕl> Ensuring medication access does not have to come at the cost of innovation Jul 16, 2024
<ѻýҕl>Pemafibrate Takes a Small Step Forward in Diabetic Foot Ulcers After CVD Flopѻýҕl> Signal of reduced ischemic ulceration, gangrene in PROMINENT Jul 15, 2024
<ѻýҕl>Mediterranean Diet Good for Kids, Teens Tooѻýҕl> Meta-analysis shows benefits for cardiometabolic health Jul 12, 2024
<ѻýҕl>Worse-Rated Cardiologists; Afib Pulsed Field Ablation Safety; Healthy Gut Microbe?ѻýҕl> Recent developments of interest in cardiovascular medicine Jul 09, 2024
<ѻýҕl>Tirzepatide Bests Semaglutide for Real-World Weight Lossѻýҕl> Injectables were compared at doses approved for type 2 diabetes Jul 08, 2024
<ѻýҕl>Popular Diabetes Drug Class Lowered Risk of 10 Obesity-Associated Cancersѻýҕl> For people with diabetes, cancer risks were reduced with GLP-1s versus insulin Jul 05, 2024
<ѻýҕl>Semaglutide May Be Linked to Condition That Causes Blindnessѻýҕl> Association with optic neuropathy in observational data needs further study to assess causality Jul 03, 2024
<ѻýҕl>Potassium Chloride Recall; Exercise vs Valve Disease; Cuffless Continuous BP Monitorѻýҕl> Recent developments of interest in cardiovascular medicine Jul 02, 2024
<ѻýҕl>Many Kids Benefit From GLP-1s. What Happens When They Have to Stop Taking Them?ѻýҕl> Prepare patients early for a time when medication is no longer an option Jul 01, 2024
<ѻýҕl>Aspirin Overuse; Biotypes of Depression and Anxietyѻýҕl> Also in TTHealthWatch: medications and the liver, and managing gestational diabetes Jun 30, 2024 podcast
<ѻýҕl>A Call to Action on Gestational Diabetesѻýҕl> Women are failed at every point, and earlier screening and later follow-up are needed, group says Jun 25, 2024
<ѻýҕl>Surprisingly High Hypercortisolism Prevalence With Uncontrolled Type 2 Diabetesѻýҕl> Many also had adrenal abnormalities Jun 25, 2024
<ѻýҕl>Novel Triple-Hormone Agonist Boosts Beta-Cell Function in T2Dѻýҕl> Insulin sensitivity also improved in people with obesity free of diabetes Jun 23, 2024
<ѻýҕl>Automated Insulin Pump Helps Type 2 Diabetes Controlѻýҕl> SECURE-T2D trial provides pivotal findings to expand use of the Omnipod 5 System Jun 23, 2024
<ѻýҕl>Tech in Diabetes: What's Going Wrong?ѻýҕl> FDA Commissioner Robert Califf, MD, talks tech Jun 21, 2024
<ѻýҕl>Donald Sutherland Dies; Can Viagra Benefit Women? Insulin Supply Affected by Wegovyѻýҕl> Health news and commentary gathered by ѻýҕl staff Jun 21, 2024
<ѻýҕl>Cardiology's Private Equity Hot Spots; Statin Overuse; Type B Blood & Heart Injuryѻýҕl> Recent developments of interest in cardiovascular medicine Jun 18, 2024
<ѻýҕl>Heat Exposure & Heart Stress; 2-Hour POC Troponin Assay; Colchicine After Stroke?ѻýҕl> Recent developments of interest in cardiovascular medicine Jun 11, 2024
<ѻýҕl>FDA Expands Use of RSV Vaccine to Include More Adultsѻýҕl> Arexvy now approved for people 50 years and older at increased risk of serious outcomes Jun 10, 2024